Episode 259 - Elegantly engineering therapies to fight cancer - Sarah Hein of March Biosciences

30 Oct 2024 • 34 min • EN
34 min
00:00
34:57
No file found

Sarah Hein is the co-founder and CEO of March Biosciences, a cancer-fighting cell therapy company that recently closed a $28.4 million series A round and is getting ready to launch its phase II trial. Sarah joins me today to discuss the past two and a half years of growing March and the role Houston and its biotech ecosystem has played in the company’s growth.

From "Houston Innovators Podcast"

Listen on your iPhone

Download our iOS app and listen to interviews anywhere. Enjoy all of the listener functions in one slick package. Why not give it a try?

App Store Logo
application screenshot

Popular categories